Tonghua Golden-Horse shareholders approve subsidiary's bank loan guarantee

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. held its third extraordinary general meeting of shareholders for 2025 on September 15, 2025. A total of 317 shareholders and their representatives, holding 207,546,714 shares (21.4742% of total company shares), attended the meeting, which combined on-site and online voting.

The primary agenda item, "Proposal on the Company Providing Guarantees for Bank Loans Applied by its Wholly-Owned Subsidiary Harbin Saint-Bio Pharmaceutical Co., Ltd.," was approved with overwhelming support. The resolution received 206,673,014 affirmative votes, representing 99.5790% of the effective voting shares. There were 449,700 dissenting votes (0.2167%) and 424,000 abstentions (0.2043%).

Among small and medium-sized investors, 16,673,014 shares voted in favor, accounting for 95.0207% of their effective voting shares. The resolution passed as a special proposal, requiring approval from over two-thirds of the effective voting rights.